Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 76

1.
2.

Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs.

Popa C, Leandro MJ, Cambridge G, Edwards JC.

Rheumatology (Oxford). 2007 Apr;46(4):626-30. Epub 2006 Dec 19.

PMID:
17189244
[PubMed - indexed for MEDLINE]
Free Article
3.

[The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences].

Bläss S, Engel JM, Burmester GR.

Z Rheumatol. 2001 Feb;60(1):1-16. Review. German.

PMID:
11263010
[PubMed - indexed for MEDLINE]
4.

[Safety of rituximab in patients with rheumatoid arthritis].

Morović-Vergles J.

Reumatizam. 2010;57(2):158-60. Croatian.

PMID:
21875022
[PubMed - indexed for MEDLINE]
5.

Long-term effects of rituximab in rheumatoid arthritis: clinical, biologic, and pharmacogenetic aspects.

Quartuccio L, Lombardi S, Fabris M, Masolini P, Saracco M, Pellerito R, De Vita S.

Ann N Y Acad Sci. 2009 Sep;1173:692-700. doi: 10.1111/j.1749-6632.2009.04668.x. Review.

PMID:
19758217
[PubMed - indexed for MEDLINE]
6.

Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis.

Rehnberg M, Amu S, Tarkowski A, Bokarewa MI, Brisslert M.

Arthritis Res Ther. 2009;11(4):R123. doi: 10.1186/ar2789. Epub 2009 Aug 17.

PMID:
19686595
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment.

Roll P, Dörner T, Tony HP.

Arthritis Rheum. 2008 Jun;58(6):1566-75. doi: 10.1002/art.23473.

PMID:
18512772
[PubMed - indexed for MEDLINE]
Free Article
8.

B-cell-targeted therapy for systemic lupus erythematosus.

Sabahi R, Anolik JH.

Drugs. 2006;66(15):1933-48.

PMID:
17100405
[PubMed - indexed for MEDLINE]
9.

Efficacy of anti-CD20 treatment in patients with rheumatoid arthritis resistant to a combination of methotrexate/anti-TNF therapy.

Bokarewa M, Lindholm C, Zendjanchi K, Nadali M, Tarkowski A.

Scand J Immunol. 2007 Oct;66(4):476-83.

PMID:
17850593
[PubMed - indexed for MEDLINE]
10.

B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives.

Nakken B, Munthe LA, Konttinen YT, Sandberg AK, Szekanecz Z, Alex P, Szodoray P.

Autoimmun Rev. 2011 Nov;11(1):28-34. doi: 10.1016/j.autrev.2011.06.010. Epub 2011 Jul 14. Review.

PMID:
21777703
[PubMed - indexed for MEDLINE]
11.

Improvement of refractory rheumatoid arthritis after depletion of B cells.

Kneitz C, Wilhelm M, Tony HP.

Scand J Rheumatol. 2004;33(2):82-6.

PMID:
15163108
[PubMed - indexed for MEDLINE]
12.

What is the role of rituximab in the treatment of rheumatoid arthritis?

Atzeni F, Doria A, Turiel M, Sarzi-Puttini P.

Autoimmun Rev. 2007 Sep;6(8):553-8. Epub 2007 Mar 7. Review. Erratum in: Autoimmun Rev. 2010 Sep;9(11):793. Maurizio, Turiel [corrected to Turiel, Maurizio].

PMID:
17854748
[PubMed - indexed for MEDLINE]
13.

B cell-directed therapy in rheumatoid arthritis--clinical experience.

Panayi GS.

J Rheumatol Suppl. 2005 Feb;73:19-24; discussion 29-30. Review.

PMID:
15693112
[PubMed - indexed for MEDLINE]
14.

B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity.

Yanaba K, Hamaguchi Y, Venturi GM, Steeber DA, St Clair EW, Tedder TF.

J Immunol. 2007 Jul 15;179(2):1369-80.

PMID:
17617630
[PubMed - indexed for MEDLINE]
Free Article
15.

Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice.

DiLillo DJ, Hamaguchi Y, Ueda Y, Yang K, Uchida J, Haas KM, Kelsoe G, Tedder TF.

J Immunol. 2008 Jan 1;180(1):361-71.

PMID:
18097037
[PubMed - indexed for MEDLINE]
Free Article
16.

Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse.

Cambridge G, Stohl W, Leandro MJ, Migone TS, Hilbert DM, Edwards JC.

Arthritis Rheum. 2006 Mar;54(3):723-32.

PMID:
16508933
[PubMed - indexed for MEDLINE]
Free Article
17.

Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis.

Roll P, Palanichamy A, Kneitz C, Dorner T, Tony HP.

Arthritis Rheum. 2006 Aug;54(8):2377-86.

PMID:
16869000
[PubMed - indexed for MEDLINE]
Free Article
18.

The effect of anti-B-cell therapy on the development of atherosclerosis in patients with rheumatoid arthritis.

Novikova DS, Popkova TV, Nasonov EL.

Curr Pharm Des. 2012;18(11):1512-8. Review.

PMID:
22364135
[PubMed - indexed for MEDLINE]
19.

B lymphocyte depletion in rheumatoid arthritis: targeting of CD20.

Edwards JC, Leandro MJ, Cambridge G.

Curr Dir Autoimmun. 2005;8:175-92.

PMID:
15564721
[PubMed - indexed for MEDLINE]
20.

[B cell depletion therapy using anti-CD20 antibodies in rheumatoid arthritis].

Yukawa N, Mimori T.

Clin Calcium. 2007 Apr;17(4):569-76. Review. Japanese.

PMID:
17404487
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk